Publicacións (24) Publicacións nas que participase algún/ha investigador/a

2024

  1. Concordancia entre las escalas de valoración del riesgo de tromboembolismo venoso en pacientes médicos en el servicio de urgencias

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias

  2. Considering nutritional status to improve outcomes of patients treated by atezolizumab–bevacizumab for advanced hepatocellular carcinoma

    Liver International

  3. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  4. DNA electroporation in a vacuum: A “shocking” innovation for vaccines

    Molecular Therapy Nucleic Acids

  5. Evidence and choice: The BCLC vision for tailoring clinical decision-making

    Journal of Hepatology

  6. First Ibero-American Summit on Lung Cancer Screening

    Archivos de Bronconeumologia

  7. From the Editor's Desk.

    Journal of Hepatology

  8. From the Editor's Desk.

    Journal of Hepatology

  9. From the Editor's Desk...

    Journal of Hepatology

  10. From the Editor's Desk...

    Journal of Hepatology

  11. From the Editor's Desk...

    Journal of Hepatology

  12. From the Editor's Desk...

    Journal of Hepatology

  13. From the Editor's Desk…

    Journal of Hepatology

  14. From the Editor's Desk…

    Journal of Hepatology

  15. From the Editor's Desk…

    Journal of Hepatology

  16. GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model

    Translational Neurodegeneration

  17. Himalaya Overall Survival Prominence and Other Routes to the Peak

    JAMA Oncology

  18. Porphyrins and the porphyrias

    Liver International

  19. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

  20. Sweet dreams could be made of this: carbohydrate-responsive element-binding protein (ChREBP) as a target for hepatocellular carcinoma therapy

    Molecular Oncology